|View printer-friendly version|
|Research Finds that Stereotaxis Robotic Technology Provides Significant Advantages in Treatment of Ventricular Tachycardia Compared to Manual Techniques|
The results of the analysis demonstrated that the Niobe system is associated with a 39% lower risk of VT recurrence (p = 0.003), higher acute procedural success during VT ablation (p = 0.0004) and a 65% reduction in risk of complications during VT ablation (p = 0.006). Additionally, procedure time was significantly shorter by an average of 9.8 min with the Niobe system (p = 0.04) and fluoroscopy time was significantly reduced by an average of 10.4 min (p < 0.00001). The publication abstract can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/28624892.
Senior author Dr.
This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe”, "estimate”, "project”, "expect" or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, the Company's ability to raise additional capital on a timely basis and on terms that are acceptable, its ability to continue to manage expenses and cash burn rate at sustainable levels, its ability to continue to work with lenders to extend, repay or refinance indebtedness, or to obtain additional financing, in either case on acceptable terms, continued acceptance of the Company's products in the marketplace, the effect of global economic conditions on the ability and willingness of customers to purchase its systems and the timing of such purchases, competitive factors, changes resulting from healthcare reform in